← Eichor
Study identifier: NCT06722742 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Use of Iv Tramadol and Ketamine for Prevention of Post Spinal Anesthesia Shivering

Condition: Shivering, Spinal Anesthesia  ·  Sponsor: Liaquat National Hospital & Medical College

PhasePhase 3
Planned participants250
Who can joinFemale, 18 Years to 40 Years
Healthy volunteersNo

About this study

\*Ketamine:\* Ketamine is a medication that can help reduce shivering by blocking certain nerve signals in the brain. It's like a "nerve blocker" that helps calm down the body's shivering response. \- \*Tramadol:\* Tramadol is a pain medication that can also help reduce shivering. It works by affecting the brain's temperature regulation centers, which helps to reduce the shivering response.

This description comes directly from the study's public registry record.

Talk to the study team

Nazish Dr Nazish Kanwal  ·  03292163092  ·  Naz98783@gmail.com

Shazor khan Khattak  ·  +92 340 2286119  ·  shazorkhan646@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Liaquat National Hospital and Medical CollegeKarachi, Sindh, PakistanRecruiting
Liaquat National Hospital and Medical CollegeKarachi, Sindh, PakistanRecruiting
Liaquat National Hospital and Medical CollegeKarachi, Sindh, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06722742